Pfizer Inc. recalls Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutan
Recalled October 11, 2017 · FDA recall D-0001-2018 · Pfizer
Hazard
CGMP Deviations: Firm failed to control impurity for color change at the API stage. · FDA Class III
Units
32,276 10 mL vials
Sold at
Nationwide
Description
CGMP Deviations: Firm failed to control impurity for color change at the API stage.
Product
Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira, Inc., Lake Forest IL USA, NDC 0406-2336-10.
Manufacturer(s)
Pfizer Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →